Hypokalemia-Induced Rhabdomyolysis From Budesonide Therapy in Crohn's Disease

We present a 71-year-old white man with active ileocolonic Crohn's disease, recently started on budesonide therapy, who presented with extreme weakness and muscle aches. He was diagnosed with hypokalemia-induced rhabdomyolysis, 3 weeks after starting budesonide therapy. His symptoms and laborat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansour, Ramy, Mandiga, Pujyitha, Thigpin, Derek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791640/
https://www.ncbi.nlm.nih.gov/pubmed/31737729
http://dx.doi.org/10.14309/crj.0000000000000201
_version_ 1783459017499082752
author Mansour, Ramy
Mandiga, Pujyitha
Thigpin, Derek
author_facet Mansour, Ramy
Mandiga, Pujyitha
Thigpin, Derek
author_sort Mansour, Ramy
collection PubMed
description We present a 71-year-old white man with active ileocolonic Crohn's disease, recently started on budesonide therapy, who presented with extreme weakness and muscle aches. He was diagnosed with hypokalemia-induced rhabdomyolysis, 3 weeks after starting budesonide therapy. His symptoms and laboratory values improved with budesonide discontinuation and appropriate fluid and electrolyte replacement. This is only the second case of hypokalemia-induced rhabdomyolysis secondary to budesonide.
format Online
Article
Text
id pubmed-6791640
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer
record_format MEDLINE/PubMed
spelling pubmed-67916402019-11-15 Hypokalemia-Induced Rhabdomyolysis From Budesonide Therapy in Crohn's Disease Mansour, Ramy Mandiga, Pujyitha Thigpin, Derek ACG Case Rep J Case Report We present a 71-year-old white man with active ileocolonic Crohn's disease, recently started on budesonide therapy, who presented with extreme weakness and muscle aches. He was diagnosed with hypokalemia-induced rhabdomyolysis, 3 weeks after starting budesonide therapy. His symptoms and laboratory values improved with budesonide discontinuation and appropriate fluid and electrolyte replacement. This is only the second case of hypokalemia-induced rhabdomyolysis secondary to budesonide. Wolters Kluwer 2019-08-29 /pmc/articles/PMC6791640/ /pubmed/31737729 http://dx.doi.org/10.14309/crj.0000000000000201 Text en © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Mansour, Ramy
Mandiga, Pujyitha
Thigpin, Derek
Hypokalemia-Induced Rhabdomyolysis From Budesonide Therapy in Crohn's Disease
title Hypokalemia-Induced Rhabdomyolysis From Budesonide Therapy in Crohn's Disease
title_full Hypokalemia-Induced Rhabdomyolysis From Budesonide Therapy in Crohn's Disease
title_fullStr Hypokalemia-Induced Rhabdomyolysis From Budesonide Therapy in Crohn's Disease
title_full_unstemmed Hypokalemia-Induced Rhabdomyolysis From Budesonide Therapy in Crohn's Disease
title_short Hypokalemia-Induced Rhabdomyolysis From Budesonide Therapy in Crohn's Disease
title_sort hypokalemia-induced rhabdomyolysis from budesonide therapy in crohn's disease
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791640/
https://www.ncbi.nlm.nih.gov/pubmed/31737729
http://dx.doi.org/10.14309/crj.0000000000000201
work_keys_str_mv AT mansourramy hypokalemiainducedrhabdomyolysisfrombudesonidetherapyincrohnsdisease
AT mandigapujyitha hypokalemiainducedrhabdomyolysisfrombudesonidetherapyincrohnsdisease
AT thigpinderek hypokalemiainducedrhabdomyolysisfrombudesonidetherapyincrohnsdisease

Ejemplares similares